Kennedy Thomas Ronan 4

Accession 0001654954-20-010735

CIK 0001644903other

View on SEC.gov Company Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 5:02 PM ET

Size

29.1 KB

Accession

0001654954-20-010735

Insider Transaction Report

Form 4

Period: 2020-10-01

cbdMD, Inc.YCBD

Kennedy Thomas Ronan

DirectorCEO and CFO

Transactions

Award
Stock option
2020-10-01+33,333→ 33,333 total
Exercise: $3.50From: 2022-10-01Exp: 2027-10-01→ Common stock (33,333 underlying)
Award
Stock option
2020-10-01+41,667→ 41,667 total
Exercise: $5.00From: 2022-10-01Exp: 2027-10-01→ Common stock (41,667 underlying)
Award
Stock option
2020-10-01+41,666→ 41,666 total
Exercise: $5.00From: 2023-10-01Exp: 2028-10-01→ Common stock (41,666 underlying)
Award
Stock option
2020-10-01+41,667→ 41,667 total
Exercise: $6.50From: 2022-10-01Exp: 2027-10-01→ Common stock (41,667 underlying)
Award
Restricted stock award
2020-10-01+16,666→ 16,666 total
Exercise: $0.00From: 2023-10-01Exp: 2023-10-01→ Common stock (16,666 underlying)
Award
Stock option
2020-10-01+33,333→ 33,333 total
Exercise: $3.50From: 2023-10-01Exp: 2028-10-01→ Common stock (33,333 underlying)
Award
Restricted stock award
2020-10-01+16,667→ 16,667 total
Exercise: $0.00From: 2021-10-01Exp: 2021-10-01→ Common stock (16,667 underlying)
Award
Stock option
2020-10-01+33,334→ 33,334 total
Exercise: $3.50From: 2021-10-01Exp: 2026-10-01→ Common stock (33,334 underlying)
Award
Restricted stock award
2020-10-01+16,667→ 16,667 total
Exercise: $0.00From: 2022-10-01Exp: 2022-10-01→ Common stock (16,667 underlying)
Award
Stock option
2020-10-01+41,667→ 41,667 total
Exercise: $5.00From: 2021-10-01Exp: 2026-10-01→ Common stock (41,667 underlying)
Award
Stock option
2020-10-01+41,667→ 41,667 total
Exercise: $6.50From: 2021-10-01Exp: 2026-10-01→ Common stock (41,667 underlying)
Award
Stock option
2020-10-01+41,666→ 41,666 total
Exercise: $6.50From: 2023-10-01Exp: 2028-10-01→ Common stock (41,666 underlying)

Footnotes (4)

[F1]Restricted stock award ("RSA") granted under the Issuer's 2015 Equity Compensation Plan (the "Plan") pursuant to the terms of the Executive Employment Agreement dated September 15, 2020, with an effective date of October 1, 2020 (the "Employment Agreement") by and between the Issuer and the Reporting Person. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2021 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
[F2]RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2022 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
[F3]RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2023 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.
[F4]Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

cbdMD, Inc.

CIK 0001644903

→

Entity typeother

Related Parties

filerCIK 0001826452

Filing Metadata

Form type: 4
Filed: Sep 30, 8:00 PM ET
Accepted: Oct 1, 5:02 PM ET
Size: 29.1 KB

View on SEC.gov